Evidence map›Paper›PMID 26206188›Full record

ReviewBiochemical pharmacology2015

Long-lasting changes in neural networks to compensate for altered nicotinic input.

Danielle John, Darwin K Berg

Abstract readReview
In one paragraph

Review in Biochemical pharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Danielle JohnNeurobiology Section, Division of Biological Sciences, University of California San Diego, La Jolla, CA 92093-0357, United States; Kavli Institute for Brain and Mind, University of California, San Diego, La Jolla, CA 92093-0357, United States.
Darwin K BergNeurobiology Section, Division of Biological Sciences, University of California San Diego, La Jolla, CA 92093-0357, United States; Kavli Institute for Brain and Mind, University of California, San Diego, La Jolla, CA 92093-0357, United States. Electronic address: dberg@ucsd.edu.
University of California, San Diego · US

Funding

Signal Transduction at Neuronal Nicotinic SynapsesR01NS012601 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BERG, DARWIN K · 1985 to 2016
$5.3M
MicroRNA101 and the Termination of Early Phase Neural DevelopmentR21NS087342 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BERG, DARWIN K · 2014 to 2015
$426k
Long-Lasting Changes in Neural Networks Induced by Early Exposure to NicotineR21DA038296 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BERG, DARWIN K · 2015 to 2016
$424k
Impact of Nicotinic Signaling through Astrocytes on Glutamate Synapse FormationR21DA034216 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BERG, DARWIN K · 2012 to 2013
$419k
NIDA NIH HHS DA038296-01NIDA NIH HHS R21 DA034216NIDA NIH HHS R21 DA038296NINDS NIH HHS NS012601-40NINDS NIH HHS NS087342-01NINDS NIH HHS R01 NS012601NINDS NIH HHS R21 NS087342
6 · The paper itself

Abstract

The nervous system must balance excitatory and inhibitory input to constrain network activity levels within a proper dynamic range. This is a demanding requirement during development, when networks form and throughout adulthood as networks respond to constantly changing environments. Defects in the ability to sustain a proper balance of excitatory and inhibitory activity are characteristic of numerous neurological disorders such as schizophrenia, Alzheimer's disease, and autism. A variety of homeostatic mechanisms appear to be critical for balancing excitatory and inhibitory activity in a network. These are operative at the level of individual neurons, regulating their excitability by adjusting the numbers and types of ion channels, and at the level of synaptic connections, determining the relative numbers of excitatory versus inhibitory connections a neuron receives. Nicotinic cholinergic signaling is well positioned to contribute at both levels because it appears early in development, extends across much of the nervous system, and modulates transmission at many kinds of synapses. Further, it is known to influence the ratio of excitatory-to-inhibitory synapses formed on neurons during development. GABAergic inhibitory neurons are likely to be key for maintaining network homeostasis (limiting excitatory output), and nicotinic signaling is known to prominently regulate the activity of several GABAergic neuronal subtypes. But how nicotinic signaling achieves this and how networks may compensate for the loss of such input are important questions remaining unanswered. These issues are reviewed.

Indexed as

Central Nervous System DiseasesCholinergic AgentsHumansNerve NetNeuronsSignal TransductionCholinergic AgentsCircuitsCompensationE/I ratioHomeostasisNeural networkNicotinic

Identifiers

PMID26206188
PMCPMC4600434
OpenAlexW987694274

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.